CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing
The Journal of Gene Medicine · 2026
DOI: 10.1002/jgm.70108 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2026. Verfasst von Weifeng Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Serine-Arginine Splicing Factors, RNA, Circular, RNA Precursors. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Quzhou Project of Science and Technology, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
Circular RNAs (circRNAs) represent key regulators in cancer pathogenesis; however, their involvement in alternative splicing (AS) remains poorly understood.
Methods
Expression of circFut8 was detected in bladder cancer ( BC ) tissues/cell lines; RNA pull‐down, cross‐linking immunoprecipitation (CLIP) assays verified circFut8's interaction with splicing factor SRSF9. CircFut8 overexpression was performed to assess its effects on BC cell proliferation in vitro (CCK‐8, colony formation) and tumor growth in vivo (xenograft models), and its modulation of FUT8 pre‐mRNA splicing was analyzed.
Results
Here, we identify circFut8—a conserved exonic circRNA originating from FUT8 gene exon 3—as a BC tumor suppressor, which is significantly downregulated in BC tissues and cell lines, correlating with advanced tumor grade and invasion. Mechanistically, circFut8 competitively binds the splicing factor SRSF9, thereby modulating the inclusion/exclusion of exon 3 in FUT8 pre‐mRNA and promoting the production of the FUT8‐4 splice variant. Functional assays confirm that circFut8 overexpression inhibits BC proliferation in vitro and suppresses tumor growth in vivo, while RNA pull‐down and cross‐linking immunoprecipitation (CLIP) assays confirm its direct interaction with SRSF9.
Conclusions
Our findings unveil a novel circRNA‐mediated regulatory axis wherein circFut8 fine‐tunes pre‐mRNA splicing through competition with SRSF9, suggesting its potential as a candidate for further therapeutic exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, Zhejiang, China.
- Department of Gynecology and Obstetrics, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Changshui Zhuang
Förderung
- Quzhou Project of Science and Technology
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Yang, W., Yao, L., Wan, L., & Zhuang, C. (2026). CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70108
Vancouver
Yang W, Yao L, Wan L, Zhuang C. CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing. The Journal of Gene Medicine. 2026. doi:10.1002/jgm.70108
BibTeX
@article{Yang2026,
author = {Yang, Weifeng and Yao, Lv and Wan, Lijun and Zhuang, Changshui},
title = {CircFut8 Suppresses Bladder Cancer by Modulating SRSF9‐Dependent Pre‐mRNA Splicing},
journal = {The Journal of Gene Medicine},
year = {2026},
doi = {10.1002/jgm.70108}
}
EUVIMED